Overall, this study unveiled the association of TTR with differences between paired P-R GBMs at both the genomic and transcriptomic levels and constructed a stable prognostic model for PFS prediction, contributing to our understanding of the GBM development and progression at recurrence and the potential for therapeutic treatments. This evidence concerns the gene TTR and glioblastoma.